Abstract:Lung adenocarcinoma (LUAD) is the most frequently observed subtype found in non-small cell lung cancer (NSCLC). Despite its high prevalence, the molecular and histological heterogeneity in LUAD pose a significant challenge for providing effective patient care and aiming to reduce the high mortality rate. The histopathological classification proposed by WHO in 2015 describes five histologic patterns of lung adenocarcinoma (lepidic, acinar, papillary, micropapillary, and solid), and it has been shown that the existence of high-grade subtypes (micropapillary and solid) is associated with poorer survival outcomes. Nevertheless, the specific cellular and molecular mechanisms responsible for these clinical outcome differences based on distinct histological patterns remain unclear. Here, we conducted single-cell RNA sequencing (scRNA-seq) to unveil insights into the tumor microenvironment (TME) and identify cancer cell biomarkers associated with distinct histological patterns. Our study involved 18 specimens from primary LUAD patients who underwent surgical resection, all of whom were previously untreated. These specimens were classified into three groups: acinar/papillary (A/P), micropapillary (MP), and solid. Remarkably, patients with solid-type tumors showed a notable enrichment of CD8+ T cell exhaustion, alongside a significant abundance of GPNMB-high macrophages in the myeloid compartment. Additionally, macrophages from the solid-type demonstrated cholesterol-efflux activation, particularly in alveolar macrophages. It is well-known that cholesterol efflux-activated macrophages display a tumor-associated macrophage phenotype, contributing to immunosuppression in the TME. In contrast, the A/P group exhibited a higher enrichment of mast cells compared to the solid-type. This suggests that the solid-type tumor landscape is more immunosuppressive than the A/P group. In the context of cancer cells, we identified that A/P cancer cells displayed a well-differentiated pattern with a high alveolar epithelial type II cell (AT2) signature. In contrast, solid-type cancer cells showed poorly differentiated states, coupled with a significant activation of the epithelial-mesenchymal transition (EMT) process. Remarkably, even within A/P patients, those with a small portion of solid patterns in the tumor tissue showed higher clonal complexity compared to patients without any solid pattern. Furthermore, we found that cancer cell plasticity can be regulated by cell-cell interactions in the TME. Collectively, this study unveils the relationship between histological patterns and the TME, encompassing distinct immune responses and molecular characteristics of cancer cells in LUAD. These findings provide valuable insights for potential targeted therapeutic strategies. Citation Format: Ju Sung Lee, Ji Yun Jeong, Mi Jeong Hong, Hyo-Gyoung Kang, Jin Eun Choi, Ju Young Kim, Yoon Ha Choi, Jong Kyoung Kim, Shin Yup Lee. Deciphering histological subtype-associated cellular and molecular characteristics of lung adenocarcinoma using single-cell RNA sequencing and spatial transcriptomics [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 2942.

Roles of naïve CD4+ T cells and their differentiated subtypes in lung adenocarcinoma and underlying potential regulatory pathways

Characterizing Tumor Microenvironment and Risk Genes in Lung Adenocarcinoma through scRNA-seq and Bulk RNA-seq Data

Cell Trajectory-Related Genes of Lung Adenocarcinoma Predict Tumor Immune Microenvironment and Prognosis of Patients

Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma

Identification of prognostic molecular subtypes and model based on CD8+ T cells for lung adenocarcinoma

Causal role of immune cells in lung cancer subtypes: Mendelian randomization study

Up-regulated tumor intrinsic growth potential and decreased immune function orchestrate the evolution of lung adenocarcinoma

Comparative immunological landscape between pre- and early-stage LUAD manifested as ground-glass nodules revealed by scRNA and scTCR integrated analysis

The CDK1-Related lncRNA and CXCL8 Mediated Immune Resistance in Lung Adenocarcinoma

Comprehensive analysis of lung adenocarcinoma: Unveiling differential gene expression, survival‐linked genes, subtype stratification, and immune landscape implications

Immune and non-immune cell subtypes identify novel targets for prognostic and therapeutic strategy: A study based on intratumoral heterogenicity analysis of multicenter scRNA-seq datasets in lung adenocarcinoma

A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma

The Predictive Role of Immune Related Subgroup Classification in Immune Checkpoint Blockade Therapy for Lung Adenocarcinoma

Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma

Abstract 2942: Deciphering histological subtype-associated cellular and molecular characteristics of lung adenocarcinoma using single-cell RNA sequencing and spatial transcriptomics

Single-cell RNA sequencing reveals distinct tumor microenvironment of ground glass nodules and solid nodules in lung adenocarcinoma

CDCA gene family promotes progression and prognosis in lung adenocarcinoma

Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinoma.

Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolution

Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma